{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["2021"],"submitter":["Hayashi Y"],"funding":["AbbVie GK"],"pubmed_abstract":["<h4>Introduction</h4>Parkinson's disease (PD) is characterized by a triad of motor symptoms and several nonmotor symptoms (NMS). Identifying the most appropriate treatment is essential for improving patient quality of life (QoL). However, it is still not known which PD symptoms more commonly affect patients with advanced PD (APD) versus non-APD. This study examined the factors that most affected the QoL of patients with APD (defined using the 5-2-1 criteria: ≥5 oral levodopa doses a day, off time ≥2 hours a day, or troublesome dyskinesia ≥1 hour a day) versus non-APD in a large Japanese population using the Japanese Quality-of-Life Survey of Parkinson's Disease (JAQPAD) study.<h4>Methods</h4>Participants in this self-reported survey-based study included all members of the Japan Parkinson's"],"journal":["Parkinson's disease"],"pagination":["9917539"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC8526216"],"repository":["biostudies-literature"],"pubmed_title":["Off Time Independently Affects Quality of Life in Advanced Parkinson's Disease (APD) Patients but Not in Non-APD Patients: Results from the Self-Reported Japanese Quality-of-Life Survey of Parkinson's Disease (JAQPAD) Study."],"pmcid":["PMC8526216"],"pubmed_authors":["Mishima T","Tsuboi Y","Ogura H","Hayashi Y","Ishido M","Nagaki K","Nakagawa R","Watanabe J","Fujioka S","Kurihara K","Yoshinaga Y"],"additional_accession":[]},"is_claimable":false,"name":"Off Time Independently Affects Quality of Life in Advanced Parkinson's Disease (APD) Patients but Not in Non-APD Patients: Results from the Self-Reported Japanese Quality-of-Life Survey of Parkinson's Disease (JAQPAD) Study.","description":"<h4>Introduction</h4>Parkinson's disease (PD) is characterized by a triad of motor symptoms and several nonmotor symptoms (NMS). Identifying the most appropriate treatment is essential for improving patient quality of life (QoL). However, it is still not known which PD symptoms more commonly affect patients with advanced PD (APD) versus non-APD. This study examined the factors that most affected the QoL of patients with APD (defined using the 5-2-1 criteria: ≥5 oral levodopa doses a day, off time ≥2 hours a day, or troublesome dyskinesia ≥1 hour a day) versus non-APD in a large Japanese population using the Japanese Quality-of-Life Survey of Parkinson's Disease (JAQPAD) study.<h4>Methods</h4>Participants in this self-reported survey-based study included all members of the Japan Parkinson's","dates":{"release":"2021-01-01T00:00:00Z","publication":"2021","modification":"2025-04-21T16:08:47.319Z","creation":"2025-04-21T16:08:47.319Z"},"accession":"S-EPMC8526216","cross_references":{"pubmed":["34676064"],"doi":["10.1155/2021/9917539"]}}